Back to top
more

ARK Genomic Revolution ETF: (ARKG)

(Delayed Data from NYSE MKT (ex. AMEX)) As of Jul 17, 2025 03:45 PM ET

$24.51 USD

24.51
1,201,147

-0.37 (-1.49%)

Volume: 1,201,147

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $24.49 -0.02 (-0.08 %) 4:26 PM ET

Zacks News

Sweta Killa headshot

4 Market-Beating Sector ETFs of the First Quarter

We have highlighted four sector ETFs that have been the quarter's star performers and could also be winners next quarter if the current trends continue.

Sweta Killa headshot

4 Best-Performing Sector ETFs of March

A few sector ETFs have easily outperformed the market and are trading in the green this month.

Sanghamitra Saha headshot

Best & Worst ETFs of Last Week

Inside the top-and-under-performing ETFs of last week.

Sweta Killa headshot

4 Best-Performing Sector ETFs of February

We have highlighted four sectors ETFs that have gained double-digits in February and could be better plays in the months ahead.

Sweta Killa headshot

Biotech ETFs Jump on Roche-Spark Deal

The news of Roche-Spark Deal has triggered speculations of merger wave in the gene therapy industry and pushed the biotech ETFs higher.

Sweta Killa headshot

Best & Worst Performing ETFs to Start 2019

We have highlighted some ETFs that are off to a good start in 2019 and some that have had a rough start.

Sweta Killa headshot

Top & Flop Zones of Q3 & Their ETFs

Some corners of ETF investing have performed exceptionally well in the third quarter while some are lagging.

    Sweta Killa headshot

    Best ETFs & Stocks From the Top Sector of Q3

    Healthcare was the best-performing sector of the third quarter, jumping 14.1% - its highest quarterly gain since the first quarter of 2013.

      Sweta Killa headshot

      4 Sector ETFs That Beat the Market in Q3

      We have highlighted four sector ETFs that have gained in double digits in the third quarter and could be better plays in the months ahead, should the trends prevail.

        Neena Mishra headshot

        Top Performing Active ETFs & Tesla's Best-Case Scenario

        Neena Mishra talks with COO of ARK Investment Management, the firm behind most innovative ETFs that have consistently delivered excellent performance.

          Sweta Killa headshot

          Should You Invest in the ARK Genomic Revolution Multi-Sector ETF (ARKG)?

          Sector ETF report for ARKG

            Sweta Killa headshot

            4 Sector ETFs That Beat the Market in August

            We have highlighted four sector ETFs that easily crushed the market in August and could be better plays in the months ahead should the trends prevail.

              Sanghamitra Saha headshot

              Top and Flop ETFs of August

              Inside the top and worst performing ETFs of August.

                Sanghamitra Saha headshot

                Genomic Revolution ETF (ARKG) Hits New 52-Week High

                This genomic revolution ETF hits a new 52-week high. Are more gains in store for this ETF?

                  Sweta Killa headshot

                  8 ETFs Up More Than 25% YTD

                  We highlight eight ETFs that have outperformed and gained more than 25% in the year-to-date time frame.

                    Zacks Equity Research

                    Should You Invest in the ARK Genomic Revolution Multi-Sector ETF (ARKG)?

                    Sector ETF report for ARKG

                      Zacks Equity Research

                      Should You Invest in the ARK Genomic Revolution Multi-Sector ETF (ARKG)?

                      Sector ETF report for ARKG

                        Zacks Equity Research

                        Should You Invest in the ARK Genomic Revolution Multi-Sector ETF (ARKG)?

                        Sector ETF report for ARKG